SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000905148-07-001383
Filing Date
2007-02-14
Accepted
2007-02-14 17:29:46
Documents
1
Group Members
GLENVIEW CAPITAL GP, LLCGLENVIEW CAPITAL MANAGEMENT, LLCLAWRENCE M. ROBBINS

Document Format Files

Seq Description Document Type Size
1 efc7-0385_911939sc13ga.txt SC 13G/A 20842
  Complete submission text file 0000905148-07-001383.txt   22927
Mailing Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117
Business Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117 8585507500
LIGAND PHARMACEUTICALS INC (Subject) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-43329 | Film No.: 07622918
SIC: 2834 Pharmaceutical Preparations

Mailing Address 767 FIFTH AVENUE 44TH FLOOR NEW YORK NY 10153
Business Address 767 FIFTH AVENUE 44TH FLOOR NEW YORK NY 10153 2128124700
GLENVIEW CAPITAL MANAGEMENT LLC (Filed by) CIK: 0001138995 (see all company filings)

IRS No.: 134136746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A